Medical Director
Orthopaedic Hemophilia Treatment Center at Orthopaedic Institute for Children Los Angeles
Los Angeles, California, United States
OC 30.2 - Efficacy and safety of valoctocogene roxaparvovec 4 years after gene transfer in GENEr8-1
Monday, June 24, 2024
09:45 – 10:00 ICT